Details

NameSymbolSector
HALEOS LABS LIMITEDHALEOSLABSPharmaceuticals
Open
1350
High
1489
Low
1350
Close
1438.7
Volume
2516
Exchange
nse
Time
28-Apr-2026

Outlook

Score:  

5.75

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Haleos Labs is  
Long Body
Estimated Stoploss of Haleos Labs is ₹  
1350
Haleos Labs has a  
Bullishℹ
 pattern. 
Formation of  
Long Body
 candle pattern indicates Haleos Labs has chances of  
Continuationℹ
 of the current trend. 

Trend

Haleos Labs is in  
Uptrendℹ
. 
Price of Haleos Labs is  
Upℹ
 by  

11.67

%. 
Target
Buy @ 

1239.9

Sell @ 

1448.3

Current @ 

1438.7

Volume

The trades of Haleos Labs have been in  
Immenseℹ
 volume. 
The volume trades for Haleos Labs are  
Bullishℹ
 with  
Strong Buyersℹ
The trade volume of Haleos Labs is  

Up

 by  

104.72

% 

Valuation

The current market price of Haleos Labs is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 389cr and total assets worth ₹ 389cr, the balance sheet of Haleos Labs is:  
Balancedℹ
. 
Cashflow
Haleos Labs has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

50% i.e. ₹ 34cr earned in operatingℹ
22.06% i.e. ₹ 15cr spent in investingℹ
27.94% i.e. ₹ 19cr spent in financingℹ
0% in otherℹ
Haleos Labs has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

50% i.e. ₹ 24cr earned in operatingℹ
37.5% i.e. ₹ 18cr spent in investingℹ
12.5% i.e. ₹ 6cr spent in financingℹ
0% in otherℹ
Income
The income of Haleos Labs is  

₹ 81cr

 and  

Profit

 is :  

₹ 6cr

(*Sep 2025)

Haleos Labs Profit is up by:  

50

% and Income is Down by:  

2.41

% 

(*Sep 2025)

The income of Haleos Labs is  

₹ 83cr

 and  

Profit

 is :  

₹ 4cr

(*Jun 2025)

Haleos Labs Profit is up by:  

33.33

% and Income is Down by:  

8.79

% 

(*Jun 2025)

The income of Haleos Labs is  

₹ 91cr

 and  

Profit

 is :  

₹ 3cr

(*Mar 2025)

Haleos Labs Profit is down by:  

25

% and Income is Up by:  

8.33

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.